CADAS138 presents itself as a novel therapeutic target in the realm of inflammatory conditions. Preclinical studies reveal significant potential for CADAS138-targeted therapies to mitigate disease progression. Researchers are currently investigating the underlying pathways of CADAS138 in disease pathogenesis, paving the way for the development of n